Company / Assets per Share
Arcus Biosciences, Inc. Assets per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$12.35
FY2025
5-year range
$12.35 / $24.45
FY2021-FY2025
Trend
-18.9%
vs FY2024
Sector context
#81 of 210
Health Care
What the data says
At $12.35, Arcus Biosciences, Inc.'s assets per share ranks #81 of 210 in the Health Care sector. Assets per Share has fluctuated over the past 9 years, ranging from $4.56 in FY2019 to $104.19 in FY2017.
Based on SEC 10-K filings.
12.35 in FY2025 with a 5-year CAGR of -6.0%.
Declined from $15.02 to $12.35 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -13.4%
- 5-Year CAGR
- -6.0%
- 10-Year CAGR
- -
Sector benchmark
#81 of 210 in Health CareTop 39% of 210This company $12.35 Sector average $353.15
▼
-96.5% below sector average
Key checks
Key Insights
- In FY2025, assets per share decreased 18.9% year-over-year.
- Ranks #81 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2017.
- Lowest assets per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -0.93 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $12.35 | -18.9% |
| FY2024 | $15.23 | +1.4% |
| FY2023 | $15.02 | -20.9% |
| FY2022 | $19.00 | -22.3% |
| FY2021 | $24.45 | +45.4% |
| FY2020 | $16.82 | +268.7% |
| FY2019 | $4.56 | -93.2% |
| FY2018 | $67.20 | -35.5% |
| FY2017 | $104.19 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026